Shockwave Medical $16.5 million supplemental term loan
Davis Polk advised Shockwave Medical, Inc. in connection with a $16.5 million supplemental term loan provided by Silicon Valley Bank. Shockwave Medical used a portion of the proceeds…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
McKesson Corporation $4 Billion Revolving Credit Agreement
Davis Polk advised the joint lead arranger and bookrunner, and the administrative agent, in connection with a $4 billion unsecured revolving credit facility provided to McKesson Corporation…
$1.075 billion financing for Option Care's combination with BioScrip
Davis Polk advised the administrative agent, joint lead arranger and joint bookrunner in connection with a $925 million first-lien term loan facility and a $150 million asset-based…
Davis Polk Advises Pernix on Completing Sale of Substantially All of Its Assets to Currax Holdings LLC
Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with the sale of substantially all of its assets to Currax Holdings LLC, an entity formed by affiliates of Highbridge…
Hologic, Inc. $3 Billion Senior Secured Credit Facilities Refinancing
Davis Polk advised the administrative agent and the lenders in connection with the refinancing of Hologic, Inc.’s existing senior secured credit facilities with a $1.5 billion term loan…
Davis Polk Advises Nutrisystem on Its Acquisition by Tivity Health
Davis Polk is advising Nutrisystem, Inc. on its $1.4 billion acquisition by Tivity Health, Inc. The transaction, which is expected to close in the first quarter of 2019, is subject to…
Davis Polk Advises Shire on Its $2.325 Billion Concurrent Tender Offers
Davis Polk advised Shire plc on concurrent tender offers by Baxalta Incorporated and Shire Acquisitions Investments Ireland DAC (“SAIIDAC”), both wholly owned subsidiaries of Shire,…
Halfmoon Parent, Inc. $20 Billion Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with an unregistered offering of $20 billion in aggregate principal amount of senior notes by Halfmoon Parent,…
Davis Polk Advises Pernix on Private Exchange Offers
Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with separate private exchange offers for its existing 12% senior secured notes due 2020 held by certain holders for new…
Valeant Pharmaceuticals International $4.565 Billion Term Loan Facility and $1.225 Billion Revolving Credit Facility
Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) and Valeant Pharmaceuticals International in connection with a $4.565 billion senior secured term loan and $1.225…